NCT03730207 - Xpede Clinical Study | Biotech Hunter

Enrollment

180

Participants

Timeline

Start Date

December 18, 2018

Primary Completion Date

October 14, 2021

Study Completion Date

October 14, 2021

Conditions

Pathological Fracture of Vertebra Due to Secondary Osteoporosis (Disorder)Pathological Fracture of Vertebra Due to Neoplastic Disease (Disorder)

Interventions

DEVICE

Xpede™ Bone Cement

Xpede™ Bone Cement will be injected into vertebral body via percutaneous Vertebroplasty or Kyphoplasty to stabilize the fractured vertebral body by filling the bony trabeculae.

DEVICE

Mendec Spine Bone Cement

Mendec Spine Bone Cement will be injected into vertebral body via percutaneous Vertebroplasty or Kyphoplasty to stabilize the fractured vertebral body by filling the bony trabeculae.

Trial Locations (3)

Unknown

The first affiliated hospital of Zhengzhou university, Zhengzhou

Hunan provincial people's hospital, Changsha

The first affiliated hospital of Suzhou university, Suzhou

All Listed Sponsors

lead

Medtronic Spinal and Biologics

INDUSTRY